• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Mediphase Venture Partners

edit

Mediphase Venture Partners is a venture capital firm focusing on health care/life sciences companies. They seek rapidly growing companies with outstanding market opportunities. They are active investors, usually joining the Boards of their portfolio companies and working closely with management to promote rapid growth. The fund managers bring an unusual combination of technical experience, operating experience, and investment experience, which can be critical to the success of an early stage company.

Milestones

edit

• 
  Mediphase Venture Partners invested in Relypsa. (9/13/10)
  Posted 9/14/10 at 5:39pm via finsmes.com
• 
  Mediphase Venture Partners invested in Tetraphase Pharmaceuticals. (6/1/10)
  Posted 6/1/10 at 5:35pm via fiercebiotech.com
• 
  Mediphase Venture Partners invested in PatientKeeper. (6/14/06)
  Posted 4/23/10 at 11:30pm via patientkeeper.com
• 
  Mediphase Venture Partners invested in Concert Pharmaceuticals. (4/30/08)
  Posted 5/25/09 at 10:37pm
• 
  Mediphase Venture Partners invested in Relypsa. (10/29/07)
  Posted 3/11/09 at 9:52am via venturebeat.com
• 
  Mediphase Venture Partners invested in Tetraphase Pharmaceuticals. (8/7/08)
  Posted 12/31/08 at 9:16pm via equityhelpdesk.com

Investments

Videos

Sources

1. Relypsa Raises $70M in Series B Financing (finsmes.com) [edit]
2. Tetraphase hauls in $45M C round to back antibiotic work (fiercebiotech.com) [edit]
3. Equity Help Desk (equityhelpdesk.com) [edit]
4. Capital Funding Report [edit]
5. Amgen, Relypsa and the art of the biotech-spinout-startup-restart (venturebeat.com) [edit]
6. PatientKeeper Closes $8 Million Financing to Support Continued Rapid Growth (patientkeeper.com) [edit]